搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 10 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), ...
How To Choose Participants For Your Emerging Leader Program
Forbes· 16 小時前Let’s start with a real story of how not to choose participants for your emerging leader program. This ...
US judge blocks some North Carolina restrictions on abortion pill
Reuters· 20 小時前A federal judge has struck down parts of a North Carolina law restricting patients' access ...